Akso Health Group current report, Q4 FY2020

SEC Filing Summary: Xiaobai Maimai Inc. (Form 6-K)

Business Context and Reporting Period

This Form 6-K was filed by Xiaobai Maimai Inc., a foreign private issuer headquartered in Beijing, China, for the month of December 2020. The filing was signed by Zhang Rui (Kerrie), Chief Financial Officer, on December 21, 2020. The document serves as a report pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.

Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document consists solely of the cover page, exhibit index, and signature block, with no financial data tables or narrative included in the provided text.

Material Changes

No material changes versus the prior comparable period are described in the provided text. The filing references an attached press release (Exhibit 99.1) but does not contain the content of that release.

Guidance, Outlook, and Risks

The filing text does not provide guidance, outlook, management commentary, risks, contingencies, or unusual items. These details are likely contained within the referenced press release which is not included in the input content.

Key Facts for Investor Verification

  • Verify the content of Exhibit 99.1 (Press Release) to obtain actual financial results or material announcements for December 2020.
  • Confirm the registrant's identity as Xiaobai Maimai Inc., noting the discrepancy with the requested company name "Akso Health Group."
  • Check subsequent filings for the full financial statements, as this 6-K is a notification of a press release rather than a financial report itself.